Article
Circular RNA encoded MET variant promotes glioblastoma tumorigenesis
25 Jul 2023
Abstract excerpt
Abstract Activated by its single ligand, hepatocyte growth factor (HGF), the receptor tyrosine kinase MET is pivotal in promoting glioblastoma (GBM) stem cell self-renewal, invasiveness and tumorigenicity. Nevertheless, HGF/MET-targeted therapy has shown limited clinical benefits in GBM patients, suggesting hidden mechanisms of MET signalling in GBM. Here, we show that circular MET RNA (circMET) encodes a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
